Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) EPS (Weighted Average and Diluted) (2023 - 2025)

Historic EPS (Weighted Average and Diluted) for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$0.16.

  • Nuvation Bio's EPS (Weighted Average and Diluted) fell 666.67% to -$0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.49, marking a year-over-year increase of 7752.29%. This contributed to the annual value of -$2113.1 for FY2024, which is 60363954.77% down from last year.
  • Per Nuvation Bio's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.16 for Q3 2025, which was down 666.67% from -$0.17 recorded in Q2 2025.
  • In the past 5 years, Nuvation Bio's EPS (Weighted Average and Diluted) registered a high of -$0.07 during Q4 2023, and its lowest value of -$183.97 during Q4 2024.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.15 (2024), whereas its average is -$16.99.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first tumbled by 26270905.11% in 2024, then soared by 9100.53% in 2025.
  • Nuvation Bio's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.07 in 2023, then crashed by 262709.05% to -$183.97 in 2024, then surged by 99.91% to -$0.16 in 2025.
  • Its last three reported values are -$0.16 in Q3 2025, -$0.17 for Q2 2025, and -$0.16 during Q1 2025.